LGI1 and encephalitis: With this setting, we obtained a specificity of 85% for both at a sensitivity of 86% in NMDAR-Ab-associated encephalitis patients (normal vs. anti-NDMAR-encephalitis) or 100% in LGI1-receptor-encephalitis patients.